Product Images Gabapentin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Gabapentin NDC 82982-067 by Pharmasource Meds, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

fab2a4bc 5409 f862 e053 6294a90a45f9

fab2a4bc 5409 f862 e053 6294a90a45f9

gabapentin label - gabapentin label

gabapentin label - gabapentin label

This appears to be a description of a prescription medication containing 90 capsules of Gabapentin, each capsule being 100 mg. The medication is dispensed with a medication guide. It is manufactured by Pharmasource Meds LLC and cannot be dispensed without a prescription as it is regulated by Federal law.*

equation of Cockcroft and Gault - gabapentin fig1

equation of Cockcroft and Gault - gabapentin fig1

This text appears to be a medical formula used to calculate a value known as "Lt". The formula involves multiplying a person's age (in years) by their weight in kilograms, and then dividing the result by their creatinine level (measured in grams per liter) which is given as 0.85 for female patients. Without additional context or information, it is difficult to determine the specific purpose or meaning of the Lt value or the formula in which it is used.*

fig-2 - gabapentin fig2

fig-2 - gabapentin fig2

The text represents a chart or graph showing the mean pain score for a 4-week period with a placebo group and a group taking 3600 mg/day of gabapentin. The pain score is represented on the vertical axis with a range from 0 to 7. The horizontal axis represents the different weeks during the 4-week period. There is not enough context to provide further information.*

fig-3 - gabapentin fig3

fig-3 - gabapentin fig3

This appears to be a table or graph with categories and numerical values. Without additional context or units of measurement, it is difficult to provide a useful description.*

Figure 3. Proportion of Responders (patients with ≥50% reduction in pain score) at Endpoint: Controlled PHN Studies - gabapentin fig4

Figure 3. Proportion of Responders (patients with ≥50% reduction in pain score) at Endpoint: Controlled PHN Studies - gabapentin fig4

The text appears to be a figure legend or caption and describes a graph titled "Proportion of Responders" in controlled studies for PHN. The graph shows the percentage of patients experiencing more than 50% reduction in pain score at endpoint with different doses of GBP. The abbreviations PBO, GBP 3600, GBP 1800, and GBP 2400 appearing on the graph likely represent different doses of medication used in the studies.*

Figure 4. Responder Rate in Patients Receiving Gabapentin Expressed as a Difference from Placebo by Dose and Study: Adjunctive Therapy Studies in Patients ≥12 Years of Age with Partial Seizures - gabapentin fig5

Figure 4. Responder Rate in Patients Receiving Gabapentin Expressed as a Difference from Placebo by Dose and Study: Adjunctive Therapy Studies in Patients ≥12 Years of Age with Partial Seizures - gabapentin fig5

Chemical Structure - gabapentin str

Chemical Structure - gabapentin str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.